CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
The 13-member CADTH Board of Directors is composed of an independent chair; a regional distribution of jurisdictional federal, provincial, and territorial representatives; and a number of non-jurisdictional representatives from health systems, academia, and the general public. Directors are elected by the Members of the Corporation, who are the Deputy Ministers of Health for participating federal, provincial, and territorial governments.
The Board has overall responsibility for administering the affairs of the Corporation and providing the strategic direction to guide CADTH's success as the Canadian "go-to" provider of evidence and advice on the use of drugs and other health technologies.
Dr. Stuart Peacock
Leslie Diamond Chair in Cancer Survivorship and Professor, Faculty of Health Sciences, Simon Fraser University; Co-Director, the Canadian Centre for Applied Research in Cancer Control (ARCC); and Distinguished Scientist in Cancer Control Research, British Columbia Cancer Agency
Dr. Luc Boileau
President and CEO, Institut national d’excellence en santé et en services sociaux (INESSS)